Recombinant Rat Tyrosine-protein kinase SYK (Syk)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. If you require a specific format, please specify this during order placement.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless otherwise requested. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline for your own protocols.
Shelf Life
Shelf life depends on several factors including storage conditions, buffer components, temperature, and the protein's inherent stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life under the same conditions.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is crucial for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is finalized during production. If you have a specific tag preference, please inform us, and we will prioritize its use.
Synonyms
SykTyrosine-protein kinase SYK; EC 2.7.10.2; Spleen tyrosine kinase; p72Syk
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-629
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Rattus norvegicus (Rat)
Target Names
Syk
Target Protein Sequence
MAGNAVDNAN HLTYFFGNIT REEAEDYLVQ GGMTDGLYLL RQSRNYLGGF ALSVAHNRKA HHYTIERELN GTYAISGGRA HASPADLCHY HSQEPEGLVC LLKKPFNRPP GVQPKTGPFE DLKENLIREY VKQTWNLQGQ ALEQAIISQK PQLEKLIATT AHEKMPWFHG NISRDESEQT VLIGSKTNGK FLIRARDNNG SFALCLLHEG KVLHYRIDRD KTGKLSIPEG KKFDTLWQLV EHYSYKPDGL LRVLTVPCQK IGVQMGHPGS SNAHPVTWSP GGIISRIKSY SFPKPGHKKP PPPQGSRPES TVSFNPYEPT GGAWGPDRGL QREALPMDTE VYESPYADPE EIRPKEVYLD RKLLTLEDNE LGSGNFGTVK KGYYQMKKVV KTVAVKILKN EANDPALKDE LLAEANVMQQ LDNPYIVRMI GICEAESWML VMEMAAWGPL NKYLQQNRHI KDKNIIELVH QVSMGMKYLE ESNFVHRDLA ARNVLLVTQH YAKISDFGLS KALRADENYY KAQTHGKWPV KWYAPECINY FKFSSKSDVW SFGVLMWEAF SYGQKPYRGM KGSEVTAMLE KGERMGCPPG CPREMYDLMF LCWTYDVENR PGFAAVELRL RNYYYDVVN
Uniprot No.

Target Background

Function

Recombinant Rat Tyrosine-protein kinase SYK (Syk)

SYK is a non-receptor tyrosine kinase that mediates signal transduction downstream of various transmembrane receptors, including key immunoreceptors such as the B-cell receptor (BCR). It plays a crucial role in numerous biological processes, encompassing innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation, and vascular development. SYK assembles into signaling complexes with activated receptors at the plasma membrane through interactions between its SH2 domains and the receptor's tyrosine-phosphorylated ITAM domains. This association can be either direct or indirect, mediated by adapter proteins containing ITAM or partial hemITAM domains. SRC subfamily kinases typically mediate the phosphorylation of ITAM domains upon receptor engagement. Less frequently, SYK signal transduction can be ITAM-independent. Direct downstream effectors phosphorylated by SYK include VAV1, PLCG1, PI-3-kinase, LCP2, and BLNK.

Initially identified as essential for BCR signaling, SYK is vital for B-cell maturation, most prominently during the pro-B to pre-B cell transition. Upon BCR engagement, it phosphorylates and activates BLNK, an adapter that links the activated BCR to downstream signaling components. It also phosphorylates and activates PLCG1 and the PKC signaling pathway, and regulates BTK activity within BCR-coupled signaling. Beyond its role in BCR signaling, SYK is also involved in T-cell receptor signaling and innate immune responses to various pathogens. For example, it's activated by the membrane lectin CLEC7A; upon stimulation by fungal proteins, CLEC7A and SYK collaboratively activate immune cells, inducing ROS production. SYK also activates the inflammasome and NF-κB-mediated transcription of chemokines and cytokines in the presence of pathogens. It further regulates neutrophil degranulation and phagocytosis via the MAPK signaling cascade and is needed for IL-15-stimulated neutrophil phagocytosis. SYK mediates dendritic cell activation by necrotic stimuli and participates in mast cell activation and IL-3-mediated signaling in basophils.

SYK functions downstream of cell adhesion receptors, relaying integrin-mediated neutrophil and macrophage activation, and P-selectin receptor/SELPG-mediated leukocyte recruitment to inflammatory sites. It also participates in non-immune processes; for instance, it's involved in vascular development, potentially regulating blood and lymphatic vascular separation, osteoclast development and function, and platelet activation by collagen, mediating PLCG2 phosphorylation and activation. SYK can be coupled to the collagen receptor by the ITAM domain-containing FCER1G and is activated by the membrane lectin CLEC1B, essential for platelet activation by PDPN/podoplanin. It is involved in platelet adhesion, being activated by ITGB3 engaged by fibrinogen. Along with CEACAM20, SYK enhances CXCL8/IL-8 cytokine production via the NFκB pathway, suggesting a role in the intestinal immune response.

Gene References Into Functions
  1. Mast cells contribute to Mincle-mediated immunity through Syk activation triggered by association with the FcepsilonRIbetagamma complex. PMID: 28393919
  2. High glucose-induced activation of the NLRP3 inflammasome is mediated by Syk/JNK activation, subsequently increasing IL-1β protein expression and mature IL-1β levels. The Syk/JNK/NLRP3 pathway may play a significant role in diabetic nephropathy pathogenesis. PMID: 29901140
  3. Cryptotanshinone inhibits IgE-mediated degranulation by inhibiting spleen tyrosine kinase and tyrosine-protein kinase phosphorylation in mast cells. PMID: 29845271
  4. Brain Syk expression is upregulated after subarachnoid hemorrhage. PMID: 26138128
  5. In simulated microgravity, ROS production in macrophages is a gravisensitive process, resulting from diminished Syk phosphorylation. PMID: 25644261
  6. Syk plays a role in acute renal allograft rejection independent of T-cell activation. PMID: 25529862
  7. Syk is crucial for Dectin-1-mediated activation of mast cells, although the signaling differs from FcRI activation. PMID: 25246527
  8. Syk is expressed and activated in antiglomerular basement membrane disease. PMID: 24700868
  9. Syk is present in various neuronal structures (cerebellum, hippocampus, visual and olfactory systems), connecting immunoreceptors to downstream molecules. PMID: 21354221
  10. Syk signaling is required for JNK and p38 MAPK signaling and acute neutrophil-dependent glomerular injury in rat nephrotoxic serum nephritis. PMID: 21894146
  11. ANG II stimulates angiogenesis via EGF receptor transactivation, promoting Flt-1 phosphorylation and Syk activation independently of VEGF expression. PMID: 21642504
  12. Syk plays a role in vascular remodeling by modulating VSMC proliferation and phenotypes. PMID: 21189061
  13. Syk is involved in vascular remodeling by altering the phenotypes and cytoskeleton of PDGF-BB-stimulated vascular smooth muscle cells. PMID: 21055270
  14. Syk may promote PDGF-BB-induced pulmonary vascular smooth muscle cell (PVSMC) proliferation. PMID: 21083985
  15. Syk activation is required for c-Cbl-mediated ubiquitination of FcepsilonRI and Syk in RBL cells. PMID: 12145291
  16. Tyr342, but not Tyr346, is crucial for regulating Syk in mast cells. PMID: 12417718
  17. Syk signaling is mediated in an ITAM-based manner by tamalin. PMID: 15173175
  18. Alpha-melanocyte stimulating hormone protects against H2O2-induced inhibition of wound healing through a Syk kinase- and NF-κB-dependent mechanism. PMID: 15489638
  19. Phosphorylation of Tyr218 of FcepsilonRI-β is crucial for Syk binding. Syk and other signaling protein recruitment to the β-subunit may be important for its amplification role. PMID: 17365510
  20. In macrophages, Syk is involved in LPS-induced intracellular signaling pathways leading to pro-inflammatory mediator release. PMID: 17621553
  21. 3D structure of Syk kinase. PMID: 18021750
  22. A positive feedback loop exists in mast cell activation where receptor-triggered Syk activation and subsequent Ca²⁺ release open Ca²⁺ release-activated Ca²⁺ channels. PMID: 18806259
  23. Redox factor-1 gene transfer inhibits neointimal formation by inhibiting the ROS-mediated Syk pathway via platelet-derived growth factor-β receptor signaling. PMID: 19038866
  24. Autophosphorylation induces conformational changes in activated Syk. Regulatory domain positioning, rather than a full opening mechanism, may modulate Syk activation. PMID: 19409513
  25. Syk couples Ca²⁺ microdomains to the activation of two spatially and temporally distinct cellular responses, highlighting the versatility of local Ca²⁺ signals in cell activation. PMID: 19584058
Database Links
Protein Families
Protein kinase superfamily, Tyr protein kinase family, SYK/ZAP-70 subfamily
Subcellular Location
Cell membrane. Cytoplasm, cytosol.

Q&A

What is Recombinant Rat Tyrosine-protein kinase SYK and what are its primary functions?

Recombinant Rat Tyrosine-protein kinase SYK (Syk) is a laboratory-produced version of the naturally occurring SYK protein found in rats. SYK functions as a non-receptor tyrosine kinase that mediates signal transduction downstream of various transmembrane receptors, particularly immunoreceptors like the B-cell receptor (BCR). It regulates several biological processes including innate and adaptive immunity, cell adhesion, osteoclast maturation, platelet activation, and vascular development .

The recombinant protein is typically produced in expression systems such as Baculovirus-infected Sf9 cells, allowing researchers to study its function in controlled laboratory conditions. SYK assembles into signaling complexes with activated receptors at the plasma membrane via interaction between its SH2 domains and receptor tyrosine-phosphorylated ITAM domains . This association can be direct or mediated by adapter proteins containing ITAM or partial hemITAM domains.

What detection methods are available for measuring Rat SYK in experimental samples?

Several methodologies can be employed to detect and quantify Rat SYK in experimental samples:

  • ELISA (Enzyme-Linked Immunosorbent Assay): Commercial kits are available with detection ranges of approximately 0.312-20 ng/mL and sensitivities around 0.156 ng/mL. These kits are suitable for detecting SYK in rat serum, plasma, and cell culture supernatants .

  • Western Blotting: This technique allows visualization of SYK protein and its phosphorylated forms using specific antibodies. When studying activation states, phospho-specific antibodies targeting the activation loop residues (Tyr518/519) should be used .

  • Immunoprecipitation followed by kinase assays: This approach enables isolation of SYK from complex mixtures and assessment of its enzymatic activity.

  • Flow Cytometry: For cellular studies, intracellular staining for SYK and phospho-SYK can be performed to analyze protein levels and activation states at the single-cell level.

When choosing a detection method, consider the experimental context, required sensitivity, and whether you need to distinguish between total SYK protein and its activated (phosphorylated) forms.

How does SYK activation occur in rat models and how can this be measured?

SYK activation in rat models occurs through a multi-step process:

  • Receptor engagement: Activation initiates when transmembrane receptors like B-cell receptors or Fc receptors engage with their ligands.

  • ITAM phosphorylation: Src family kinases phosphorylate ITAM domains on receptors or associated adapter proteins.

  • SYK recruitment: SYK is recruited to phosphorylated ITAMs via its tandem SH2 domains.

  • Activation loop phosphorylation: SYK becomes activated through phosphorylation of tyrosines in its activation loop (Tyr518/519 in rat SYK) .

  • Signal propagation: Activated SYK phosphorylates downstream substrates including PLCG1, PI-3-kinase, and various adapter proteins.

SYK activation can be measured through:

  • Western blotting with phospho-specific antibodies: Detecting phosphorylation at Tyr518/519 in the activation loop.

  • In vitro kinase assays: Measuring the ability of immunoprecipitated SYK to phosphorylate substrates.

  • Phosphoflow cytometry: Analyzing SYK phosphorylation at the single-cell level.

Research has shown that SYK activation follows an exponential pattern due to a "chain reaction" effect, where initially activated SYK molecules can phosphorylate and activate additional SYK molecules .

How can I design experiments to investigate SYK-dependent signaling pathways in rat immune cells?

Designing experiments to investigate SYK-dependent signaling requires careful consideration of several factors:

Experimental Design Framework:

  • Define your variables precisely:

    • Independent variable: SYK activation status or expression level

    • Dependent variables: Downstream signaling events, cellular responses

    • Control variables: Cell type, stimulation conditions, etc.

  • Select appropriate experimental approaches:

    • Genetic manipulation: Use siRNA knockdown, CRISPR-Cas9 gene editing, or overexpression of wild-type or mutant SYK

    • Pharmacological intervention: Apply SYK-specific inhibitors at various concentrations

    • Immunological stimulation: Activate relevant receptors using antibodies or ligands

  • Include proper controls:

    • Positive controls: Stimulate with known SYK activators

    • Negative controls: Use SYK-deficient cells or SYK inhibitors

    • Specificity controls: Include kinase-dead SYK mutants (e.g., K395R mutation)

Example experimental design for studying SYK-dependent BCR signaling:

GroupTreatmentReadout
1No stimulation (baseline)Phospho-SYK, phospho-BLNK, Ca²⁺ flux
2Anti-IgM stimulationPhospho-SYK, phospho-BLNK, Ca²⁺ flux
3Anti-IgM + SYK inhibitorPhospho-SYK, phospho-BLNK, Ca²⁺ flux
4SYK siRNA + Anti-IgMPhospho-SYK, phospho-BLNK, Ca²⁺ flux
5SYK-K395R expression + Anti-IgMPhospho-SYK, phospho-BLNK, Ca²⁺ flux

When analyzing results, apply appropriate statistical tests and consider the kinetics of signaling events, as SYK activation can occur rapidly and exhibit exponential characteristics .

What methodological approaches can distinguish between Src-initiated and SYK auto-phosphorylation in experimental systems?

Distinguishing between Src-initiated phosphorylation and SYK auto-phosphorylation requires sophisticated experimental approaches:

1. Kinase-Dead Mutant Strategy:
Utilize a kinase-dead SYK mutant (SYK-K) with a K395R mutation that eliminates ATP binding capability while maintaining the protein's structure. This mutant cannot perform auto-phosphorylation but can still be phosphorylated by other kinases like Src family members .

Experimental approach:

  • Express wild-type SYK or SYK-K in cells

  • Stimulate relevant receptors

  • Immunoprecipitate SYK and analyze tyrosine phosphorylation

  • Interpretation: Phosphorylation observed on SYK-K must come from other kinases (e.g., Src), while additional phosphorylation seen on wild-type SYK likely represents auto-phosphorylation

2. Temporal Analysis with Selective Inhibitors:
Use selective inhibitors of Src family kinases and analyze the timing of SYK phosphorylation events.

Experimental protocol:

  • Pre-treat cells with selective Src inhibitors (e.g., PP2)

  • Stimulate receptors at various timepoints

  • Analyze SYK phosphorylation by Western blot

  • Interpretation: Early phosphorylation events blocked by Src inhibitors indicate Src-initiated phosphorylation; later events that persist despite Src inhibition may represent SYK auto-phosphorylation

3. In Vitro Reconstitution Assays:
Perform in vitro kinase assays with purified components.

Procedure:

  • Incubate purified inactive SYK with active Src kinase and ATP

  • In parallel, incubate active SYK alone with ATP

  • Analyze phosphorylation patterns by mass spectrometry

  • Compare phosphorylation sites to identify those preferentially targeted by Src versus SYK itself

Research has demonstrated that SYK activation involves both Src-initiated phosphorylation and a subsequent "chain reaction" of SYK auto-phosphorylation, which explains the exponential kinetics of SYK activation following receptor engagement .

How should I design experiments to investigate SYK's role in rat models of neuroinflammation and neurodegeneration?

Investigating SYK's role in neuroinflammation and neurodegeneration, particularly in rat models, requires specialized experimental approaches:

Experimental Design Considerations:

  • Select appropriate disease models: Consider 5×FAD rats for Alzheimer's disease research, which develop amyloid-β plaques and neuroinflammation .

  • Employ cell-specific manipulation: Use conditional knockout systems like Cx3cr1-CreERT2 for microglia-specific SYK deletion .

  • Define appropriate timepoints: Include both early stages (before pathology) and late stages to capture disease progression.

  • Select relevant readouts: Measure microglial activation, phagocytosis, inflammatory markers, and cognitive outcomes.

Methodology for Studying SYK in Microglia:

The following experimental approach has been validated in rodent models:

  • Generate microglia-specific SYK knockout using tamoxifen-inducible Cre system:

    • Cross Syk^fl/fl mice with Cx3cr1-CreERT2 mice

    • Administer tamoxifen at 1 month of age for 1 month

    • Allow 4+ weeks for peripheral myeloid cell turnover while microglia maintain deletion

  • Assess microglial activation and phenotypes:

    • Perform flow cytometry with markers such as CD11c, CLEC7A, CD74

    • Conduct single-cell RNA sequencing to identify microglial subpopulations

    • Compare disease-associated microglia (DAM) signatures between SYK-sufficient and SYK-deficient conditions

  • Analyze amyloid pathology and microglia-plaque interactions:

    • Quantify Aβ plaque burden with immunohistochemistry

    • Assess microglia clustering around plaques

    • Measure ApoE production by microglia, which is partially SYK-dependent

Example experimental design table:

GroupGenotypeTreatmentTimepointsAssessments
1Syk^fl/fl × Cx3cr1-CreERT2Tamoxifen6, 9 monthsscRNA-seq, IHC, behavior
2Syk^fl/flTamoxifen6, 9 monthsscRNA-seq, IHC, behavior
35×FAD × Syk^fl/fl × Cx3cr1-CreERT2Tamoxifen6, 9 monthsscRNA-seq, IHC, behavior
45×FAD × Syk^fl/flTamoxifen6, 9 monthsscRNA-seq, IHC, behavior

Research has shown that SYK deficiency in microglia hampers the development of disease-associated microglia (DAM) phenotypes in Alzheimer's disease models, highlighting SYK's role in microglial responses to amyloid pathology .

What controls and validation steps are essential when studying recombinant Rat SYK activity in vitro?

When studying recombinant Rat SYK activity in vitro, implementing proper controls and validation steps is crucial to ensure reliable and reproducible results:

Protein Quality Controls:

  • Purity assessment: Verify >90% purity using SDS-PAGE with Coomassie staining .

  • Western blot confirmation: Confirm identity using SYK-specific antibodies.

  • Mass spectrometry validation: Verify the molecular weight and sequence coverage.

  • Batch-to-batch consistency: Compare activity levels across different production batches.

Activity Validation:

  • Kinase-dead control: Include a K395R mutant version that lacks kinase activity but maintains structure .

  • Substrate specificity: Verify phosphorylation of known SYK substrates (e.g., BLNK, PLCγ1).

  • Phosphorylation site mapping: Confirm phosphorylation at activation loop residues (Y518/Y519).

  • Dose-response curves: Generate activity profiles across a range of enzyme concentrations.

Buffer and Reaction Condition Optimization:

  • pH optimization: Test activity across pH range 6.5-8.0.

  • Divalent cation requirements: Verify Mg²⁺ or Mn²⁺ requirements and optimal concentrations.

  • ATP concentration: Determine Km for ATP and use appropriate concentration.

  • Temperature sensitivity: Assess activity at different temperatures.

Validation Experiment Example:

SampleEnzymeSubstrateATPInhibitorActivity (pmol/min)
1Active SYKCustom peptide100 μMNone[Expected range]
2SYK K395RCustom peptide100 μMNone<5% of active
3Active SYKCustom peptide100 μMR406 (1 μM)<10% of sample 1
4No enzymeCustom peptide100 μMNoneBackground only
5Active SYKNo substrate100 μMNoneBackground only

Inhibitor Response Profiling:

Testing response to known SYK inhibitors provides validation of proper folding and active site integrity:

  • Establish baseline activity with optimized conditions

  • Test dose-response with established SYK inhibitors (e.g., R406, PRT062607)

  • Calculate IC50 values and compare to published literature

  • Verify selectivity using inhibitors of other kinases

These controls and validation steps ensure that observed activities are specifically attributable to SYK and that the recombinant protein faithfully represents the native enzyme's properties .

How do I troubleshoot inconsistent results when studying SYK-dependent signaling in rat primary cells?

Troubleshooting inconsistent results when studying SYK-dependent signaling in rat primary cells requires systematic evaluation of multiple experimental parameters:

Cell Isolation and Culture Variables:

  • Animal variables: Age, sex, and strain of rats can significantly affect SYK expression and activation. Use age-matched and sex-matched animals when possible.

  • Isolation procedure: Harsh isolation methods may pre-activate cells. Monitor baseline phosphorylation of SYK and downstream targets in freshly isolated cells.

  • Culture conditions: Primary cells may lose signaling capacities over time in culture. Establish a consistent time window for experiments after isolation.

Troubleshooting approach: Isolate cells from multiple animals in parallel and compare baseline and stimulated SYK activation. If variability persists, standardize isolation protocols with gentler methods.

Stimulation Conditions:

  • Receptor expression: Surface receptor levels may vary between preparations. Verify receptor expression by flow cytometry.

  • Antibody/ligand quality: Batch-to-batch variation in stimulatory antibodies or ligands can affect results. Use consistent lots or pool and aliquot reagents.

  • Stimulation kinetics: SYK activation can be rapid and transient. Perform detailed time-course experiments to identify optimal timepoints.

Standardization protocol: Create a standard curve for stimulation by titrating the activating agent and measuring both proximal (SYK phosphorylation) and distal (e.g., calcium flux) readouts.

Detection Methods:

  • Antibody specificity: Verify phospho-SYK antibody specificity using SYK-deficient cells or cells treated with SYK inhibitors.

  • Lysis conditions: Inadequate lysis or phosphatase activity during lysis can affect results. Use phosphatase inhibitors and validate lysis conditions.

  • Signal normalization: Always normalize phospho-SYK signals to total SYK protein levels.

Troubleshooting strategy: If Western blot results are inconsistent, use alternative methods such as flow cytometry or ELISA to confirm findings .

Experimental Controls to Include:

Control TypePurposeImplementation
Positive controlVerify signaling capacityStimulate with PMA/ionomycin or pervanadate
Negative controlEstablish baselineInclude unstimulated cells
Inhibitor controlConfirm SYK-dependencePre-treat subset with SYK inhibitor
Loading controlEnsure equal proteinProbe for housekeeping proteins
Cross-validationVerify activationMeasure multiple outputs (e.g., phospho-SYK and phospho-PLC-γ1)

Case Study: Troubleshooting Thy-1-mediated SYK Activation:

Research has shown that when studying Thy-1-mediated SYK activation in rat basophilic leukemia cells, inconsistent results were initially obtained. Investigation revealed that the extent of SYK phosphorylation was dependent on the degree of Thy-1 aggregation, with increased phosphorylation observed only when extensive aggregation was induced using two layers of cross-linking reagents . This illustrates how subtle differences in stimulation protocols can dramatically affect SYK activation outcomes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.